Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
did not go back for the second dose of the series; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a adult male patient who had not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (first dose was received on 14-NOV-2023 to left arm). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: did not go back for the second dose of the series). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 14-OCT-2025 The reporter was patient itself. The reporter mentioned that the patient had plan on going back for the second dose. The batch number was not provided, and we are unable to contact the reporter.